Study identifies risk potential for thousands of mutations of a cancer gene
Scientists have characterized the role of thousands of mutations in the BRCA2 cancer gene, findings that may help reassure ...
J&J's combo extends patients' lives in head-to-head study with AstraZeneca's drug
Johnson & Johnson said on Tuesday its chemotherapy-free combination treatment showed a meaningful improvement in extending ...
Paxlovid may help some long COVID patients: Research
A small study published Monday found that the COVID-19 antiviral treatment Paxlovid may have use as a treatment for long ...
AstraZeneca: Uncertainty Ahead, Neutral Rating Confirmed.
Analysis of AstraZeneca's market potential, including China and IRA impacts, and the importance of key readouts in 2025 for ...
AstraZeneca Files Flurry of Lawsuits to Protect Cancer Treatment Drug
This complaint was first surfaced by Law.com Radar, ALM's source for immediate alerting on just-filed cases in state and federal courts. Law.com Radar now offers state court coverage nationwide. Sign ...
AstraZeneca PLC Investor Alert: Shareholder Rights Law Firm Robbins LLP Reminds Shareholders of the Class Action Against AZN
SAN DIEGO, CA / ACCESSWIRE / January 9, 2025 / Robbins LLP reminds investors that a class action was filed on behalf of all ...
AstraZeneca’s Promising Pipeline and Strategic Initiatives Drive Buy Recommendation
AstraZeneca (AZN – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Sachin Jain from Bank ...
Alzheimer’s could be diagnosed 10 years earlier after world’s largest blood proteins study
Alzheimer’s disease could be diagnosed up to a decade earlier after the world’s biggest study of proteins is completed. The ...
3 Cheap Growth Stocks to Buy in 2025
As we enter 2025, many growth stocks are trading at high valuations and could be running out of room to rise in the near term ...
Vietnam Investment Reviev4d
AstraZeneca joins efforts for universal health coverage
AstraZeneca has been taking a wider role in Vietnam’s healthcare sector to help expand access to quality healthcare.
AstraZeneca rises Thursday, outperforms market
Shares of AstraZeneca PLC AZN rose 2.18% to £109.88 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising 0.83% to 8,319.69.